CTOs on the Move

Integrated Health Network of Wisconsin

www.ihnwi.com

 
Integrated Health Network (IHN) of Wisconsin is the state’s first multi-system, clinically integrated accountable care network and one of the first in the United States. It is a consortium of independent health systems, hospitals and physicians working together to improve the quality, efficiency and value of health care. Since its launch in 2010, IHN has been transforming health care delivery with our clinically integrated network of leading health care providers and our sophisticated infrastructure for data analytics. The result is a model that delivers high quality health care and the cost savings of a narrow network, combined with the scale and ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.ihnwi.com
  • 19601 W. Bluemound Road Suite 200
    Brookfield, WI USA 53045
  • Phone: 262.696.3675

Executives

Name Title Contact Details

Similar Companies

Vermont Gyms d/b/a Synergy Fitness

Vermont Gyms Incorporated d/b/a Synergy Fitness is a Williston, VT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CityVet™

CityVet Veterinary Care - exceptional care with services include Boarding, Bathing, Grooming, Veterinary Care and Food & Supplies with locations in Dallas, TX, Houston, TX and Denver, CO.

Tocagen

Tocagen is a clinical stage, biopharmaceutical company pursuing the discovery, development and commercialization of gene therapy products for the treatment of cancer.

Ampio Pharmaceuticals

Ampio is an innovative drug discovery and development company combining scientific, regulatory, and business capabilities to efficiently develop a robust portfolio of novel therapeutic candidates.  These therapeutic candidates, if approved, will address significant inflammatory conditions for which limited treatment options exist. Ampio’s therapeutic product pipeline has been developed through more than two decades of study at leading hospital-based research centers. Rigorous preclinical and clinical research efforts have yielded a diverse portfolio of late-stage product candidates focusing on the world’s most prevalent inflammatory conditions including osteoarthritis and diabetic macular edema. Significant discoveries in both basic science and clinical research have resulted in Ampio receiving over 180 patents throughout the world, with hundreds more pending.  Further, hundreds of peer-reviewed publications, abstracts, and scientific presentations highlight the depth of research supporting Ampio’s therapeutic product candidates. Ampio’s leading product candidates are Ampion™ and Optina™.  The company is currently conducting the second pivotal clinical trial in the US for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee.  Ampio is also conducting a late-stage US clinical trial for Optina, an oral agent being studied for the treatment of diabetic macular edema.  Millions of patients worldwide are affected by these conditions, for which limited treatment options exist. At Ampio, we strive to offer compelling therapeutic options for the patients most in need of new treatments, and we operate every day to advance our products’ development and make these available to patients.

Titan Health Corporation

Titan Health Corporation is a Sacramento, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.